Effect of Neoadjuvant Chemotherapy with Pirarubicin,Cyclophosphamide and Nab-Paclitaxel on Ki-67,MMP-9, Vascular Endothelial Growth Factor and Prognosis in Patients with Triple Negative Breast Cancer

HAN Xiao-jun; SU Mei; YANG Qiao; XU Guo-qiang; GAN Ji-mei

doi:10.3969/j.issn.1002-3429.2022.09.014

Home>Articles>Effect of Neoadjuvant Chemotherapy with Pirarubicin,Cyclophosphamide and Nab-Paclitaxel on Ki-67,MMP-9, Vascular Endothelial Growth Factor and Prognosis in Patients with Triple Negative Breast Cancer

DOI: 10.3969/j.issn.1002-3429.2022.09.014

Effect of Neoadjuvant Chemotherapy with Pirarubicin,Cyclophosphamide and Nab-Paclitaxel on Ki-67,MMP-9, Vascular Endothelial Growth Factor and Prognosis in Patients with Triple Negative Breast Cancer

HAN Xiao-jun

SU Mei

YANG Qiao

XU Guo-qiang

GAN Ji-mei

Machine-generated Keywords：

Publication Date：2022-09-22

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 58-62 )

Clinical Misdiagnosis & Mistherapy

ISTIC

ISSN：1002-3429

Year, Vol.(Issue)：2022,35(9)